Current Neuro-Oncology

Volume 5 Number 4
30 April 2003

Home > Publications > Current Neuro-Oncology > Volume 5, Year 2003 > Number 4, 30 April

Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN.
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Cancer Res. 2003 Apr 1;63(7):1602-7
. PMID: 12670911. Laboratory investigation.

Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jääskeläinen J, Ram Z.
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Neuro Oncol. 2003 Apr 1;5(2):79-88
. doi: 10.1093/neuonc/5.2.79. PMID: 12672279. Phase 3 trial.

Taylor RE, Bailey CC, Robinson K, Weston CL, Ellison D, Ironside J, Lucraft H, Gilbertson R, Tait DM, Walker DA, Pizer BL, Imeson J, Lashford LS; International Society of Paediatric Oncology; United Kingdom Children's Cancer Study Group.
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
J Clin Oncol. 2003 Apr 15;21(8):1581-91
. doi: 10.1200/JCO.2003.05.116. PMID: 12697884. Prospective study.